The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
Open accessAbstract
BACKGROUND: Although it is presumed that exacerbations of chronic obstructive pulmonary disease (COPD) are associated with increased airway inflammation, there is little information available on inflammatory markers during an exacerbation and the relationship with severity or time course of recovery. A study was undertaken to investigate the sputum cell and cytokine characteristics of COPD when stable and during an exacerbation. METHODS: Induced sputum samples from 57 patients with moderate to severe COPD were analysed (44 samples were taken during a stable period and 37 during an exacerbation). The patients recorded daily symptoms on diary cards. Cell counts and sputum levels of interleukin (IL)-6 and IL-8 were measured. RESULTS: Patients with >/=3 exacerbations/year had higher median stable sputum levels of IL-6 (110 (95% CI 11 to 215) pg/ml) and IL-8 (6694 (95% CI 3120 to 11995) pg/ml) than those with </=2 exacerbations/year (22 (95% CI 12 to 93) and 1628 (95% CI 607 to 4812) pg/ml, respectively). Median IL-6 levels were increased during exacerbations compared with stable conditions. The levels of IL-6 during exacerbations were related to the presence of a cold and to the total cell count and eosinophil and lymphocyte numbers, while IL-8 was positively correlated with all sputum cell counts. Sputum cell counts and cytokine levels during an exacerbation did not predict the size and duration of lung function changes in the exacerbation. CONCLUSIONS: Patients with more frequent exacerbations have higher baseline sputum cytokine levels, which may predict the frequency of future exacerbations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,492
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., PAUL, E. A., BESTALL, J. C., JEFFRIES, D. J., & WEDZICHA, J. A. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.5.9709032 · Cited by 2,312
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
Baggiolini, M., Walz, A., & Kunkel, S. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114265 · Cited by 1,975
Keatings, V. M., Collins, P. D., Scott, D. M., & Barnes, P. J. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.2.8564092 · Cited by 1,362
Use of induced sputum cell counts to investigate airway inflammation in asthma.
Pin, I., Gibson, P. G., Kolendowicz, R., Girgis-Gabardo, A., Denburg, J. A., Hargreave, F. E., & Dolovich, J. (1992) · Thorax · doi:10.1136/thx.47.1.25 · Cited by 913
The natural history of chronic bronchitis and emphysema
Little, G. M. (1979) · Resuscitation · doi:10.1016/0300-9572(79)90018-2 · Cited by 600
Airway eosinophilia in chronic bronchitis during exacerbations.
Saetta, M., Di Stefano, A., Maestrelli, P., Turato, G., Ruggieri, M. P., Roggeri, A., Calcagni, P., Mapp, C. E., Ciaccia, A., & Fabbri, L. M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.6.7952628 · Cited by 536
Allergic respiratory disease: strategic targets for primary prevention during childhood
Holt, P. G., & Sly, P. D. (1997) · Thorax · doi:10.1136/thx.52.1.1 · Cited by 464
BTS Guidelines for the Management of Chronic Obstructive Pulmonary Disease
(1997) · Thorax · doi:10.1136/thx.52.2008.s1.5 · Cited by 446
Role of Infection in Chronic Bronchitis
Tager, I., & Speizer, F. E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197503132921105 · Cited by 421
Cited by
Inflammatory responses and inflammation-associated diseases in organs
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2018) · Oncotarget · doi:10.18632/oncotarget.23208 · Cited by 5,143
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A., Locantore, N., Müllerova, H., Tal-Singer, R., Miller, B., Lomas, D. A., Agusti, A., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,981
Donaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
Chronic obstructive pulmonary disease: molecular and cellularmechanisms
Barnes, P. J., Shapiro, S. D., & Pauwels, R. A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00040703 · Cited by 1,439
COPD exacerbations: Defining their cause and prevention
Wedzicha, J. A., & Seemungal, T. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61382-8 · Cited by 1,370
Self-citationTime Course and Recovery of Exacerbations in Patients with Chronic Obstructive Pulmonary Disease
SEEMUNGAL, T. A. R., DONALDSON, G. C., BHOWMIK, A., JEFFRIES, D. J., & WEDZICHA, J. A. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9908022 · Cited by 1,179
Self-citationBafadhel, M., McKenna, S., Terry, S., Mistry, V., Reid, C., Haldar, P., McCormick, M., Haldar, K., Kebadze, T., Duvoix, A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0597oc · Cited by 1,094
Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430407 · Cited by 1,078
SEEMUNGAL, T., HARPER-OWEN, R., BHOWMIK, A., MORIC, I., SANDERSON, G., MESSAGE, S., MacCALLUM, P., MEADE, T. W., JEFFRIES, D. J., JOHNSTON, S. L., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2105011 · Cited by 1,018
Self-citationThe cytokine network in asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36130 · Cited by 982
Mediators of Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.2 · Cited by 710
Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
Kanoh, S., & Rubin, B. K. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00078-09 · Cited by 708
Patel, I. S. (2002) · Thorax · doi:10.1136/thorax.57.9.759 · Cited by 690
COPD exacerbations: definitions and classifications
Burge, S., & Wedzicha, J. A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00078002 · Cited by 664
Bafadhel, M., McKenna, S., Terry, S., Mistry, V., Pancholi, M., Venge, P., Lomas, D. A., Barer, M. R., Johnston, S. L., Pavord, I. D., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1553oc · Cited by 612
Cellular and Structural Bases of Chronic Obstructive Pulmonary Disease
SAETTA, M., TURATO, G., MAESTRELLI, P., MAPP, C. E., & FABBRI, L. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.6.2009116 · Cited by 552
Antibiotic Treatment of Exacerbations of COPD
Stolz, D., Christ-Crain, M., Bingisser, R., Leuppi, J., Miedinger, D., Müller, C., Huber, P., Müller, B., & Tamm, M. (2007) · Chest · doi:10.1378/chest.06-1500 · Cited by 521
Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD
Donaldson, G. C., Hurst, J. R., Smith, C. J., Hubbard, R. B., & Wedzicha, J. A. (2010) · Chest · doi:10.1378/chest.09-2029 · Cited by 514
Chronic Bronchitis and Chronic Obstructive Pulmonary Disease
Kim, V., & Criner, G. J. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201210-1843ci · Cited by 513
Cellular and Molecular Mechanisms of Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2014) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.10.004 · Cited by 488
Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD
Donaldson, G. C., Seemungal, T. A. R., Patel, I. S., Bhowmik, A., Wilkinson, T. M. A., Hurst, J. R., MacCallum, P. K., & Wedzicha, J. A. (2005) · Chest · doi:10.1378/chest.128.4.1995 · Cited by 480
Self-citationAARON, S. D., ANGEL, J. B., LUNAU, M., WRIGHT, K., FEX, C., LE SAUX, N., & DALES, R. E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.2.2003122 · Cited by 466
Exacerbations of chronic obstructive pulmonary disease
Celli, B. R., & Barnes, P. J. (2007) · European Respiratory Journal · doi:10.1183/09031936.00109906 · Cited by 462
Bronchiectasis, Exacerbation Indices, and Inflammation in Chronic Obstructive Pulmonary Disease
Patel, I. S., Vlahos, I., Wilkinson, T. M. A., Lloyd-Owen, S. J., Donaldson, G. C., Wilks, M., Reznek, R. H., & Wedzicha, J. A. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200305-648oc · Cited by 460
Lung microbiome dynamics in COPD exacerbations
Wang, Z., Bafadhel, M., Haldar, K., Spivak, A., Mayhew, D., Miller, B. E., Tal-Singer, R., Johnston, S. L., Ramsheh, M. Y., Barer, M. R., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01406-2015 · Cited by 459
Use of Plasma Biomarkers at Exacerbation of Chronic Obstructive Pulmonary Disease
Hurst, J. R., Donaldson, G. C., Perera, W. R., Wilkinson, T. M. A., Bilello, J. A., Hagan, G. W., Vessey, R. S., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-506oc · Cited by 454
Seemungal, T. A. R., Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., Sapsford, R. J., & Wedzicha, J. A. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-145oc · Cited by 444
COPD exacerbations {middle dot} 2: Aetiology
Sapey, E. (2006) · Thorax · doi:10.1136/thx.2005.041822 · Cited by 437
Willemse, B. W. M., Postma, D. S., Timens, W., & ten Hacken, N. H. T. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00012704 · Cited by 433
Mallia, P., Message, S. D., Gielen, V., Contoli, M., Gray, K., Kebadze, T., Aniscenko, J., Laza-Stanca, V., Edwards, M. R., Slater, L., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0833oc · Cited by 415
The Cytokine Network in Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0220tr · Cited by 412
Oxidative stress and airway inflammation in severe exacerbations of COPD
Drost, E. M. (2005) · Thorax · doi:10.1136/thx.2004.027946 · Cited by 389
Inflammatory Response and Body Composition in Chronic Obstructive Pulmonary Disease
EID, A. A., IONESCU, A. A., NIXON, L. S., LEWIS-JENKINS, V., MATTHEWS, S. B., GRIFFITHS, T. L., & SHALE, D. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.8.2008109 · Cited by 376
Inflammatory changes, recovery and recurrence at COPD exacerbation
Perera, W. R., Hurst, J. R., Wilkinson, T. M. A., Sapsford, R. J., Müllerova, H., Donaldson, G. C., & Wedzicha, J. A. (2007) · European Respiratory Journal · doi:10.1183/09031936.00092506 · Cited by 372
COPD exacerbations {middle dot} 1: Epidemiology
Donaldson, G. C. (2006) · Thorax · doi:10.1136/thx.2005.041806 · Cited by 371
Airway Bacterial Load and FEV 1 Decline in Patients with Chronic Obstructive Pulmonary Disease
Wilkinson, T. M. A., Patel, I. S., Wilks, M., Donaldson, G. C., & Wedzicha, J. A. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1179oc · Cited by 370
Physiology and pathophysiology of human airway mucus
Hill, D. B., Button, B., Rubinstein, M., & Boucher, R. C. (2022) · Physiological Reviews · doi:10.1152/physrev.00004.2021 · Cited by 366
Effects of Fluticasone on Systemic Markers of Inflammation in Chronic Obstructive Pulmonary Disease
Sin, D. D., Lacy, P., York, E., & Man, S. F. P. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-543oc · Cited by 347
Remodeling and Inflammation of Bronchi in Asthma and Chronic Obstructive Pulmonary Disease
Jeffery, P. K. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200402-009ms · Cited by 347
Hurst, J. R., Perera, W. R., Wilkinson, T. M. A., Donaldson, G. C., & Wedzicha, J. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-704oc · Cited by 346
Burgel, P.-R., Nesme-Meyer, P., Chanez, P., Caillaud, D., Carré, P., Perez, T., & Roche, N. (2009) · Chest · doi:10.1378/chest.08-2062 · Cited by 346
Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease
Seemungal, T. A. R., Harper-Owen, R., Bhowmik, A., Jeffries, D. J., & Wedzicha, J. A. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.16d19.x · Cited by 334
Self-citationEffective mucus clearance is essential for respiratory health
Randell, S. H., & Boucher, R. C. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0082sf · Cited by 335
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers
Willemse, B. W. M., ten Hacken, N. H. T., Rutgers, B., Lesman-Leegte, I. G. A. T., Postma, D. S., & Timens, W. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00108904 · Cited by 322
Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., Wilks, M., Donaldson, G. C., & Wedzicha, J. A. (2006) · Chest · doi:10.1378/chest.129.2.317 · Cited by 317
Exacerbations and Time Spent Outdoors in Chronic Obstructive Pulmonary Disease
Donaldson, G. C., Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., & Wedzicha, J. A. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1054oc · Cited by 316
Pulmonary Biomarkers in Chronic Obstructive Pulmonary Disease
Barnes, P. J., Chowdhury, B., Kharitonov, S. A., Magnussen, H., Page, C. P., Postma, D., & Saetta, M. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200510-1659pp · Cited by 298
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
Gompertz, S., O'Brien, C., Bayley, D. L., Hill, S. L., & Stockley, R. A. (2001) · European Respiratory Journal · doi:10.1183/09031936.01.99114901 · Cited by 292
New Concepts in Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152209 · Cited by 290
Hypothesis: Does COPD have an autoimmune component?
Agusti, A. (2003) · Thorax · doi:10.1136/thorax.58.10.832 · Cited by 279
Biernacki, W. A. (2003) · Thorax · doi:10.1136/thorax.58.4.294 · Cited by 276
Exacerbations of Chronic Obstructive Pulmonary Disease
(2016) · Respiratory Infections · doi:10.3109/9781420080353-7 · Cited by 270
Stolz, D., Christ-Crain, M., Morgenthaler, N. G., Leuppi, J., Miedinger, D., Bingisser, R., Müller, C., Struck, J., Müller, B., & Tamm, M. (2007) · Chest · doi:10.1378/chest.06-2336 · Cited by 270
Role of Viruses in Exacerbations of Chronic Obstructive Pulmonary Disease
Wedzicha, J. A. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.2306030 · Cited by 261
COPD: current therapeutic interventions and future approaches
Barnes, P. J., & Stockley, R. A. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00139104 · Cited by 259
Association between Glycemic State and Lung Function: The Framingham Heart Study
Walter, R. E., Beiser, A., Givelber, R. J., O'Connor, G. T., & Gottlieb, D. J. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2203022 · Cited by 254
Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease
Wedzicha, J. A., Brill, S. E., Allinson, J. P., & Donaldson, G. C. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-181 · Cited by 253
Exacerbation rate, health status and mortality in COPD – a review of potential interventions
Seemungal, T. (2009) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s3385 · Cited by 197
Chin, C. L., Manzel, L. J., Lehman, E. E., Humlicek, A. L., Shi, L., Starner, T. D., Denning, G. M., Murphy, T. F., Sethi, S., & Look, D. C. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200412-1687oc · Cited by 151
Sajjan, U. S., Jia, Y., Newcomb, D. C., Bentley, J. K., Lukacs, N. W., LiPuma, J. J., Hershenson, M. B., Sajjan, U. S., Jia, Y., Newcomb, D. C., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5806fje · Cited by 146
Macrophage heterogeneity in respiratory diseases
Boorsma, C. E., Draijer, C., & Melgert, B. N. (2013) · Mediators of Inflammation · doi:10.1155/2013/769214 · Cited by 126
Cellular senescence in the lung across the age spectrum
Parikh, P., Wicher, S., Khandalavala, K., Pabelick, C. M., Britt, R. D., & Prakash, Y. S. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00424.2018 · Cited by 112
Bellinghausen, C., Gulraiz, F., Heinzmann, A. C. A., Dentener, M. A., Savelkoul, P. H. M., Wouters, E. F., Rohde, G. G., & Stassen, F. R. (2016) · Respiratory Research · doi:10.1186/s12931-016-0382-z · Cited by 71
Bewley, M. A., Belchamber, K. B. R., Chana, K. K., Budd, R. C., Donaldson, G., Wedzicha, J. A., Brightling, C. E., Kilty, I., Donnelly, L. E., Barnes, P. J., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163139 · Cited by 64
Payne, C. M., Burke, L. P., Cavanagh, B., O’Toole, D., Cryan, S.-A., & Kelly, H. M. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2583-x · Cited by 17
Metadata
- Authors
- Bhowmik, A.
- Venue
- Thorax
- Publisher
- BMJ
- Published
- 2000-02-01
- Volume
- 55
- Issue
- 2
- Pages
- 114-120
- ISSN
- 0040-6376 (ISSN-L)
- OpenAlex
- W2086872426
- Cited by
- 730
- References
- 29
- FWCI
- 24.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.